C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2001
11/28/2001	CN1324214A Utilization of an antifungal protein fron streptomyces tendae against plant pathogenic fungi
11/28/2001	CN1324211A Manipulation of tocopherol levels in transgenic plants
11/27/2001	US6323396 Agrobacterium-mediated transformation of plants
11/27/2001	US6323393 Nucleotide sequences for use as tools in genetic engineering
11/27/2001	US6323390 Transgenic mouse models for human bladder cancer
11/27/2001	US6323322 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/27/2001	US6323321 Monoclonal antibody which binds to an antigen on the megakaryocytic cell for use as diagnostic tool
11/27/2001	US6323184 Arteriovenous and venous graft treatments: methods and compositions
11/27/2001	US6323178 Beta-lipotropin methods
11/27/2001	US6323029 Therapeutic, diagnostic, and research applications for the modulation of glycogen synthase kinase 3 beta expression
11/27/2001	US6323028 Isolated peptides which comply with HLA-CW16 molecules and uses
11/27/2001	US6323027 Common gamma chain monoclonal antibody blocking agents
11/27/2001	US6323026 Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
11/27/2001	US6323025 In vitro cell culture in media containing beta-alanyl-taurine or carbobenzoxy beta-alanyl-taurine
11/27/2001	US6323019 Design of novel highly efficient HIV based packaging systems for gene therapy
11/27/2001	US6323017 Enzymatic polypeptide for prevention and treatment of asthma, exudative tympanitis, hemorrhagic colitis and adult respiratory distress syndrome
11/27/2001	US6323011 Providing trans-ferulic acid or its salt; combining with enzyme activity i, enzyme activity ii, and enzyme activity iii, wherein enzyme activity i, enzyme activity ii, and enzyme activity iii catalyze the production of vanillin
11/27/2001	US6323008 Methods for producing sialyloligosaccharides in a dairy source
11/27/2001	US6323003 Compositions and methods for activating genes of interest
11/27/2001	US6323002 Methods for modifying the production of a polypeptide
11/27/2001	US6323000 To identify compounds that interact with it
11/27/2001	US6322999 Cloned genes coding for human receptors, and cell lines expressing genes, in order to generate a proper screen for human therapeutic compounds
11/27/2001	US6322967 Recombinant tryptophan mutants of influenza
11/27/2001	US6322804 Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic products
11/27/2001	US6322795 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
11/27/2001	US6322792 Gamma-2 herpes viruses like kaposi's sarcoma-associated herpes virus useful in modulating persistence of heterologous dna; gene therapy
11/27/2001	US6322791 Haemopoietic growth factor antagonists and uses therefor
11/27/2001	US6322790 Treatment of primary and metastatic noeplastic diseases and infectious diseases; administering antigen presenting cells sensitized with complexes of hsps noncovalently bound to an antigenic molecule
11/27/2001	US6322787 Induction of an anti-tumor immunity by redirecting tumor cells against antigen-presenting cells
11/27/2001	US6322786 Growing saos-2 cells, removing culture medium with serum, washing, incubating, collecting culture medium without serum, filtering, obtaining desired retentate
11/27/2001	US6322785 Platelet-rich-plasma activated by calcium chloride solution, and an aqueous suspension of partially frayed type i collagen
11/27/2001	US6322784 Glucocorticoid, a compound which stimulates camp production and compound which upregulates peroxisome proliferator activated receptor .gamma. expression
11/27/2001	US6322781 Production of recombinant baculoviruses
11/27/2001	CA2241266C Enzyme composition for tissue dissociation
11/27/2001	CA2178004C Indicator cell line for detecting rna viruses and method therefor
11/27/2001	CA2083286C Recombinant fibrinogenases, preparation and use thereof
11/27/2001	CA2080693C Composite living skin equivalents
11/27/2001	CA2021912C Erythropoietin (epo) peptides and antibodies directed against these
11/26/2001	CA2322554A1 Cell culture and method for production
11/22/2001	WO2001088198A1 Antisense modulation of tert expression
11/22/2001	WO2001088182A2 Lipid bilayer array methods and devices
11/22/2001	WO2001088165A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence
11/22/2001	WO2001088148A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001	WO2001088141A2 Synthetic gagpol genes and their uses
11/22/2001	WO2001088138A1 Humanised antibodies to the epidermal growth factor receptor
11/22/2001	WO2001088136A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	WO2001088132A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	WO2001088125A1 MUTATION IN THE β2 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT ASSOCIATED WITH NOCTURNAL FRONTAL LOBE EPILEPSY
11/22/2001	WO2001088118A1 Novel motor proteins and methods for their use
11/22/2001	WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001088106A2 Novel deoxyribonucleside kinase enzyme multi-substrate variants
11/22/2001	WO2001088105A2 Production of dendritic cells from bone-marrow stem cells
11/22/2001	WO2001088104A2 Neural progenitor cell populations
11/22/2001	WO2001088103A2 Compositions and methods for tissue dedifferentiation and regeneration
11/22/2001	WO2001088102A1 Method for preventing allograft rejection
11/22/2001	WO2001088101A2 CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT
11/22/2001	WO2001088100A1 Novel method of inducing the differentiation of embryonic stem cells into ectodermal cells and use thereof
11/22/2001	WO2001088098A2 Fertilization of aged oocytes
11/22/2001	WO2001088097A1 Immune potentiating compositions
11/22/2001	WO2001088085A2 Novel bee venom polypeptides and methods of use thereof
11/22/2001	WO2001087982A2 Immunotoxin fusion proteins and means for expression thereof
11/22/2001	WO2001087981A2 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/22/2001	WO2001087980A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	WO2001087937A2 G-protein coupled receptors
11/22/2001	WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001	WO2001087934A2 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides
11/22/2001	WO2001087932A2 Seven transmembrane proteins and polynucleotides encoding the same
11/22/2001	WO2001087931A2 Bacterial insecticidal proteins
11/22/2001	WO2001087350A2 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001	WO2001087346A2 Dendritic cells loaded with toxic substances
11/22/2001	WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	WO2001087337A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	WO2001087330A2 Compositions and methods for achieving immune suppression
11/22/2001	WO2001087327A1 Method for cell adhesion and wound healing
11/22/2001	WO2001087325A1 Method to increase class i presentation of exogenous antigens by human dendritic cells
11/22/2001	WO2001087237A2 Apparatus and process for in situ manufacture of essence from living, uncut plants
11/22/2001	WO2001087192A1 Tissue engineered stents
11/22/2001	WO2001087071A1 Methods for enriching for quiescent cells in hematopoietic cell populations
11/22/2001	WO2001087062A2 Microinjection of cryoprotectants for preservation of cells
11/22/2001	WO2001087039A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
11/22/2001	WO2001087037A1 Methods for modulating the proliferation of hematopoietic cells
11/22/2001	WO2001064848A9 Method and apparatus for culturing cell or tissue
11/22/2001	WO2001055333A8 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/22/2001	WO2001038355A3 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof
11/22/2001	WO2001036650A3 An oncolytic adenovirus
11/22/2001	WO2001036639A3 Bt toxin receptors from lepidopteran insects and methods of use
11/22/2001	WO2001036476A3 Ing2, an iaps associated cell cycle protein, compositions and methods of use
11/22/2001	WO2001036463A3 Genes specifically expressed in human dendritic cells
11/22/2001	WO2001036462A3 Protein c derivatives
11/22/2001	WO2001035995A3 Tr3-specific binding agents and methods for their use
11/22/2001	WO2001034805A3 Human vanilloid receptor gene
11/22/2001	WO2001031036A3 Modified viral surface proteins which bind to cells of tumor vasculature
11/22/2001	WO2001031035A3 Heterologous production of polyketides
11/22/2001	WO2001030986A3 Human pif1 dna helicase and uses thereof
11/22/2001	WO2001027268A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
11/22/2001	WO2001027146A3 Chemokine receptor
11/22/2001	WO2001023597A9 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus

1 ... 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 ... 1827